EXE Expand Energy

Expand Energy (formerly Chesapeake Energy) is one of the largest US natural gas producers, with operations concentrated in the Marcellus, Haynesville, and Eagle Ford shale plays. Sector: Energy.

Expand Energy (EXE) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

On the question of capital productivity, ROIC is 14.59%, WACC is 6.11%, and the economic spread is 8.48%. On balance, returns on capital just exceed funding costs, implying limited but real value creation at the margin. Supporting metrics show ROE at 17.61% and ROA at 10.55%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

From a market pricing perspective, trailing P/E of 7.35, forward P/E of 11.45, PEG of 1.34. With trailing and forward P/E closely aligned, the market appears to be pricing the company on the assumption that earnings remain broadly stable near term. The PEG ratio suggests the market may be underpricing the company's growth trajectory relative to its current multiple. The company carries an aggregate current ratio of 1.11, pointing to constrained near-term balance sheet coverage. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

The margin stack reads as follows: gross margin sits at 49.84%, operating margin at 33.10%, and free cash flow margin at 20.55%. The gross margin reading points to the company with solid but not outsized pricing power relative to direct costs. At this level, operating margins reflect businesses with genuine scalability and above-average cost control. FCF margins are constructive here, reflecting the company that generate cash reliably after reinvestment requirements. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

The forward view combines two signals: the estimated 12-month price change of 30.12%, where the forward target set implies considerable headroom versus current levels, while TTM revenue growth of 100.23% suggesting the company is collectively capturing meaningful market share or pricing power. The forward EPS growth estimate of -35.8% is negative, which complicates the valuation case and suggests current multiples may not be as defensible on a forward basis. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.